Answer
The esomeprazole component of VIMOVO inhibits H+K+-ATPase, the acid pump in gastric parietal cells, reducing both basal and stimulated gastric acid secretion.
Sources for this answer
- VIMOVO 500 mg/20 mg modified-release tabletsGrunenthal Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 21Document updated
Sources checked